<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2024 [PPXK5GW761L0VE62FUE4]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:12pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>Washington, D.C. 20549</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>FORM S-8</B></P>
<P align=center style='font:12pt Times New Roman;margin-top:3.45pt;margin-bottom:0pt;margin-left:2pt'><B>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</B></P>
<P align=center style='font:12pt Times New Roman;margin-top:3.45pt;margin-bottom:0pt;margin-left:2pt'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin-top:3.45pt;margin-bottom:0pt;margin-left:2pt'><FONT style='border-bottom:1px solid #000000'><B>Myc</B><B>o</B><B>topia Therapies Inc.</B></FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0;margin-left:0.05pt'>(Exact name of registrant as specified in its charter)</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>Nevada</B></FONT></P>
</TD><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>87-0645794</B></FONT></P>
</TD></TR>
<TR><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'>(State or other jurisdiction of <BR>incorporation or organization)</P>
</TD><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'>(I.R.S. Employer <BR>Identification No.)</P>
</TD></TR>
</TABLE>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>100 SE 2nd St</B>, <B>Suite 2000, Miami, FL</B></FONT></P>
</TD><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>33131</B></FONT></P>
</TD></TR>
<TR><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'>(Address of Principal Executive Offices)</P>
</TD><TD valign=top style=width:50%><P align=center style='font:12pt Times New Roman;margin:0'>(Zip Code)</P>
</TD></TR>
</TABLE>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>MYCOTOPIA THERAPIES INC. 2024 EQUITY INCENTIVE PLAN</B></FONT></P>
<P align=center style='font:12pt Times New Roman;margin:0'>(Full title of the plan)</P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>InCorp Services Inc.</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>9107 West Russell Road Suite 100, Las Vegas, NV, 89148</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>(800) 246-2677</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin-top:2.55pt;margin-bottom:0pt'>(Name and address of agent for service)</P>
<P align=center style='font:12pt Times New Roman;margin:0;margin-left:0.05pt'>(Telephone number, including area code, of agent for service)</P>
<P align=center style='font:12pt Times New Roman;margin-top:11.2pt;margin-bottom:0pt'>With copies to:</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>Jonathan D. Leinwand, P.A.</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>18305 Biscayne Blvd, Suite 200</B></P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>Aventura, FL 33160</B></P>
<P style='font:11pt Times New Roman;margin-top:11.2pt;margin-bottom:0pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:2pt'>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &quot;emerging growth company&quot; in Rule 12b-2 of the Exchange Act.</P>
<P style='font:12pt Times New Roman;margin:0;margin-left:2pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>Large accelerated filer <FONT style='font:10pt Wingdings'><FONT face=Wingdings>&#168;</FONT></FONT></P>
</TD><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>Accelerated filer <FONT style='font:10pt Wingdings'><FONT face=Wingdings>&#168;</FONT></FONT></P>
</TD></TR>
<TR><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>Non-accelerated filer <FONT style='font:10pt Wingdings'><FONT face=Wingdings>&#120;</FONT></FONT></P>
</TD><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>Smaller reporting company <FONT style='font:10pt Wingdings'><FONT face=Wingdings>&#120;</FONT></FONT></P>
</TD></TR>
<TR><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:50%><P style='font:12pt Times New Roman;margin:0'>Emerging growth company <FONT style='font:10pt Wingdings'><FONT face=Wingdings>&#168;</FONT></FONT></P>
</TD></TR>
</TABLE>
<P align=justify style='font:12pt Times New Roman;margin-top:9.9pt;margin-bottom:0pt;margin-left:2pt'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Aptos;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'>PART I</P>
<P align=center style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</P>
<P style='font:12pt Aptos;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><B>Item 1. Plan Information.</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants in the Mycotopia Therapies, Inc. 2024 Equity Incentive Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Such documents are not being filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) but constitute, along with the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Form S-8, a prospectus that meets the requirements of Section 10(a) of the Securities Act.</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><B>Item 2. Registrant Information and Employee Plan Annual Information.</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>Mycotopia Therapies, Inc. (the &#8220;Company&#8221;) will furnish without charge to each person to whom the prospectus is delivered, upon the written or oral request of such person, a copy of any and all of the documents incorporated by reference in Item 3 of Part II of this Registration Statement, other than exhibits to such documents (unless such exhibits are specifically incorporated by reference to the information that is incorporated) and any other documents required to be delivered pursuant to Rule 428(b) under the Securities Act. Those documents are incorporated by reference in the Section 10(a) prospectus. Requests should be directed to the Secretary of the Company at the address and telephone number on the cover of this Registration Statement.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Arial;margin-top:0pt;margin-bottom:6pt;color:#000000'><FONT style='font-family:Times New Roman'>PART II</FONT></P>
<P align=center style='font:12pt Arial;margin-top:0pt;margin-bottom:12pt;color:#000000'><FONT style='font-family:Times New Roman'>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</FONT></P>
<P style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000'><B>Item 3. Incorporation of Document by Reference.</B></P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-indent:36pt;color:#000000'>The following documents have previously been filed by the Company with the Commission and are incorporated herein by reference:</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;margin-left:54pt;color:#000000'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:-18pt'>a.</KBD>The Company&#8217;s annual report on Form 10-K for the year ending December 31, 2023&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;margin-left:54pt;color:#000000'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:-18pt'>b.</KBD>The Company&#8217;s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024.&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;margin-left:54pt;color:#000000'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:-18pt'>c.</KBD>The Company&#8217;s Current Reports on Form 8-K filed with the Securities and Exchange Commission on March 28, 2024 and August 21, 2024.&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:3pt;margin-left:54pt;color:#000000'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:-18pt'>d.</KBD>The description of the Company&#8217;s securities as set forth in Item 11 of the Company&#8217;s filing on Form 10, filed with the SEC on June 10, 2019, as amended, and any other amendment or report filed for the purpose of updating such description.&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:3pt;color:#000000'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:3pt;color:#000000'>All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing such documents.</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:3pt;color:#000000'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:3pt;color:#000000'>The Company will provide, without charge to each person, including any beneficial owner, to whom this document is delivered, upon written or oral request of such person, a copy of any or all of the documents incorporated herein by reference (other than exhibits, unless such exhibits specifically are incorporated by reference into such documents or this document). Requests for such documents should be submitted in writing, addressed to the office of the Secretary, Mycotopia Therapies Inc. 100 SE 2nd St, Suite 2000, Miami, FL 33131</P>
<P align=justify style='font:12pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'><B>Item 4. Description of Securities.</B></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'>Not applicable.</P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'><B>Item 5. Interests of Named Experts and Counsel.</B></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'>Not applicable.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><B>Item 6.&#160;&#160;&#160;&#160;&#160;&#160;Indemnification of Directors and Officers</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>Nevada law permits a Nevada corporation, such as the Company, to indemnify its directors and officers in certain circumstances. Specifically, Section 78.7502 of the Nevada Revised Statutes provides as follows:</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><KBD style='position:absolute;font:12pt Aptos;margin-left:36pt'>(1)</KBD><KBD style=margin-left:72pt></KBD>A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or&#160;in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to Nevada Revised Statutes 78.138 or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was unlawful.&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:36pt'>(2)</KBD><KBD style=margin-left:72pt></KBD>A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company, against expenses, including amounts paid in settlement and attorneys&#8217; fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification pursuant to this section may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of any appeals taken therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><KBD style='position:absolute;font:12pt Times New Roman;margin-left:36pt'>(3)</KBD><KBD style=margin-left:72pt></KBD>Any discretionary indemnification pursuant to this section, unless ordered by a court or advanced pursuant to subsection 2 of Nevada Revised Statutes 78.751, may be made by the corporation only as authorized in each specific case upon a determination that the indemnification of a director, officer, employee or agent of a corporation is proper under the circumstances. The determination must be made by: (a) the stockholders; (b) the board of directors, by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or (c)&#8194;Independent legal counsel, in a written opinion, if: (1)&#8194;A majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding so orders; or (2)&#8194;A quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained.&#8221;&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>The articles of incorporation of the Company provide that the Company shall indemnify, to the fullest extent legally permissible under the laws of the State of Nevada, each person who is or was a director or officer of the Company, or is or was serving as the request of the Company as a director or officer of another enterprise, and that the foregoing right of indemnification shall not exclude any other right to which a director or officer may be entitled under any bylaw, agreement, vote of stockholders, provision of law or otherwise. The Company&#8217;s articles of incorporation also provide that no director or officer shall be personally liable to the corporation or its stockholders for damages for breach of fiduciary duty as a director or officer except for circumstances involving acts or omissions involving intentional misconduct, fraud or a knowing violation of law, or for unlawful distributions in violation of Section 78.300 of the Nevada Revised Statutes.</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>The bylaws of the Company provide that (i) the Company shall indemnify any person who is or was a director, officer (including the legal spouse of a director or officer), employee or agent of the Company; and (ii) the Company shall also indemnify any person who serves or served as a director, officer (including the legal spouse of such director or officer), employee or agent of any other enterprise at the request of the Company, if such person acted in good faith and in a manner reasonably believed to be in or not opposed to the best interest of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The indemnification of a legal spouse of a director or officer shall not extend to any claim for any actual or alleged wrongful act of the spouse but shall apply only to actual or alleged wrongful acts of a director or officer. The Company&#8217;s bylaws also provide that expenses incurred in defending any civil or criminal action, suit or proceeding by any person who the Company is required to indemnify shall be paid as they are incurred upon receipt by the Company of an undertaking of such person to repay such expenses unless it should ultimately be determined that such person is entitled to be indemnified by the Company. The Company maintains director&#8217;s and officers&#8217; liability insurance.</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>The foregoing is only a general summary of certain aspects of Nevada law, the Company&#8217;s articles of incorporation and bylaws, and the insurance dealing with indemnification of directors and officers and does not purport to be complete. It is qualified in its entirety by reference to the detailed provisions of Nevada law, the Company&#8217;s articles of incorporation and bylaws, and the insurance policies.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><B>Item 8. Exhibits</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>Exhibit No.</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.12%><P align=justify style='font:12pt Times New Roman;margin:0'>Description</P>
</TD><TD valign=top style=width:1.1%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:30.96%><P align=justify style='font:12pt Times New Roman;margin:0'>Location</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:17.74%;border-top:1.5pt solid #45B0E1'><P align=justify style='font:12pt Times New Roman;margin:0'>4.1</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:1.08%;border-top:1.5pt solid #45B0E1'><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:49.12%;border-top:1.5pt solid #45B0E1'><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href='http://www.sec.gov/Archives/edgar/data/1763329/000144586619000419/twgl_ex3z01.htm' style=text-decoration:none>Amended and Restated Articles of Incorporation of 20/20 Global, Inc.</A></FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:1.1%;border-top:1.5pt solid #45B0E1'><P style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:30.96%;border-top:1.5pt solid #45B0E1'><P style='font:12pt Times New Roman;margin:0'>Incorporated by reference from the registration statement on Form 10 filed April 15, 2019</P>
</TD></TR>
<TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>4.2</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href='http://www.sec.gov/Archives/edgar/data/1763329/000109690621002102/tpia_ex3z4.htm' style=text-decoration:none>Amendment to Articles of Incorporation</A></FONT></P>
</TD><TD valign=top style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Incorporated by reference from the Quarterly Report on Form 10-Q</P>
<P style='font:12pt Times New Roman;margin:0'>Filed on August 20, 2021</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>4.3</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href='http://www.sec.gov/Archives/edgar/data/1763329/000144586619000419/twgl_ex3z02.htm' style=text-decoration:none>Bylaws of 20/20 Global, Inc.</A></FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Incorporated by reference from the registration statement on Form 10 filed April 15, 2019</P>
</TD></TR>
<TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>4.4</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href='http://www.sec.gov/Archives/edgar/data/1763329/000109690621001228/tpia_ex3z3.htm' style=text-decoration:none>Amendment to Bylaws</A></FONT>.</P>
</TD><TD valign=top style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Incorporated by reference from the Quarterly Report on Form 10-Q filed May 20, 2021</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>4.5</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex4z5.htm style=text-decoration:none>Mycotopia Therapies Inc. 2024 Equity Incentive Plan</A></FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Filed Herewith</P>
</TD></TR>
<TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>5.1</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex5z1.htm style=text-decoration:none>Opinion of Jonathan D. Leinwand, P.A.</A></FONT></P>
</TD><TD valign=top style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Filed Herewith</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>23.1</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex5z1.htm style=text-decoration:none>Consent of </A><A href=tpia_ex5z1.htm style=text-decoration:none>Jonathan D. Leinwand, P.A.</A></FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>included in Exhibit 5.1</P>
</TD></TR>
<TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>23.2</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex23z2.htm style=text-decoration:none>Consent of F</A><A href=tpia_ex23z2.htm style=text-decoration:none>ruci</A><A href=tpia_ex23z2.htm style=text-decoration:none> and Associates II LLP</A></FONT></P>
</TD><TD valign=top style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Filed Herewith</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>23.3</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:49.12%><P style='font:12pt Aptos;margin:0'><FONT style='font-family:Times New Roman;color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex23z3.htm style=text-decoration:none>Consent of Pinnacle Accountancy Group of Utah</A></FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Filed Herewith</P>
</TD></TR>
<TR><TD valign=top style=width:17.74%><P align=justify style='font:12pt Times New Roman;margin:0'>107</P>
</TD><TD valign=top style=width:1.08%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.12%><P style='font:12pt Times New Roman;margin:0'><FONT style='color:#467886;border-bottom:1px solid #467886'><A href=tpia_ex107.htm style=text-decoration:none>Filing Fee Table</A></FONT></P>
</TD><TD valign=top style=width:1.1%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:30.96%><P style='font:12pt Times New Roman;margin:0'>Filed Herewith</P>
</TD></TR>
</TABLE>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'><B>Item 9. Undertakings</B></P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt'>(a)<B>&#160;&#160;&#160;&#160;</B>The undersigned registrant hereby undertakes:</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt'>(1)&#160;&#160;&#160;&#160;To file, during any period in which offers or sales are being made, a post-</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>effective amendment to this Registration Statement:</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>(i)&#160;&#160;&#160;&#160;To include any prospectus required by section 10(a)(3) of the Securities&#160;Act of 1933&#894;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>(ii)&#160;&#160;&#160;&#160;To reflect in the prospectus any facts or events arising after the&#160;effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated </P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:12pt Times New Roman;margin:0;margin-left:72pt'>maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#894;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>(iii)&#160;&#160;&#160;&#160;To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement&#894; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:72pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:72pt'>(2)&#160;&#160;&#160;&#160;That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:72pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt'>(3)&#160;&#160;&#160;&#160;To remove from registration by means of a post-effective amendment any of the&#160;securities being registered which remain unsold at the termination of the offering.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt'>(b)&#160;&#160;&#160;&#160;The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed&#160;to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0;text-indent:36pt;color:#000000'>(c)&#160;&#160;&#160;&#160;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0;color:#000000'><B>SIGNATURES</B></P>
<P align=justify style='font:12pt Times New Roman;margin-top:12pt;margin-bottom:0pt;text-indent:24.5pt;color:#000000'>Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&#160;S-8&#160;and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, on this 27th day of August, 2024.</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:52.6%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:47.4%><P style='font:12pt Times New Roman;margin:0'>MYCOTOPIA THERAPIES, INC.</P>
</TD></TR>
<TR><TD valign=top style=width:52.6%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:4.14%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:43.26%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:52.6%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:4.14%><P style='font:12pt Times New Roman;margin:0'>By:</P>
</TD><TD valign=top style='width:43.26%;border-bottom:0.5pt solid #000000'><P style='font:12pt Times New Roman;margin:0'>/s/ Benjamin Kaplan</P>
</TD></TR>
<TR><TD valign=top style=width:52.6%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:4.14%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:43.26%;border-top:0.5pt solid #000000'><P style='font:12pt Times New Roman;margin:0'>Benjamin Kaplan,</P>
</TD></TR>
<TR><TD valign=top style=width:52.6%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:4.14%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:43.26%><P style='font:12pt Times New Roman;margin:0'>Chief Executive Officer <BR>(Principal Executive</P>
</TD></TR>
<TR><TD valign=top style=width:52.6%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:4.14%><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:43.26%><P style='font:12pt Times New Roman;margin:0'>Officer, Principal Financial Officer)</P>
</TD></TR>
</TABLE>
<P style='font:12pt Times New Roman;margin:0;margin-left:0.9pt'>&nbsp;</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='width:23.18%;border-bottom:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'><B>Signature</B></P>
</TD><TD valign=bottom style=width:2%;padding-bottom:1.5pt><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style='width:49.8%;border-bottom:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'><B>Title</B></P>
</TD><TD valign=bottom style=width:2%;padding-bottom:1.5pt><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style='width:23.02%;border-bottom:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'><B>Date</B></P>
</TD></TR>
<TR><TD valign=bottom style='width:23.18%;border-top:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style='width:49.8%;border-top:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style='width:23.02%;border-top:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=bottom style='width:23.18%;border-bottom:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'><I>/s/ Benjamin Kaplan</I></P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:49.8%><P align=justify style='font:12pt Times New Roman;margin:0'>Chief Executive Officer and Director</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:23.02%><P align=justify style='font:12pt Times New Roman;margin:0'>September 13, 2024</P>
</TD></TR>
<TR><TD valign=bottom style='width:23.18%;border-top:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'>Benjamin Kaplan</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:49.8%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:23.02%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=bottom style=width:23.18%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:49.8%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:23.02%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR><TD valign=bottom style='width:23.18%;border-bottom:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'><I>/s/ Mark Croskery</I></P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=bottom style=width:49.8%><P align=justify style='font:12pt Times New Roman;margin:0'>Director </P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:23.02%><P align=justify style='font:12pt Times New Roman;margin:0'>September 13, 2024</P>
</TD></TR>
<TR><TD valign=bottom style='width:23.18%;border-top:0.5pt solid #000000'><P align=justify style='font:12pt Times New Roman;margin:0'>Mark Croksery</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:49.8%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:2%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:23.02%><P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P align=justify style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "tpia_s8.htm", "description": "MYCOTOPIA THERAPIES INC. - S-8", "secsgml_size_bytes": 45570}]
{"company-data": {"conformed-name": "Mycotopia Therapies, Inc.", "cik": "0001763329", "assigned-sic": "2833", "organization-name": "03 Life Sciences", "irs-number": "870645794", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-282128", "film-number": "241298805"}, "business-address": {"street1": "480 22ND STREET", "city": "HEYBURN", "state": "ID", "zip": "83336", "phone": "208-677-2020"}, "mail-address": {"street1": "480 22ND STREET", "city": "HEYBURN", "state": "ID", "zip": "83336"}, "former-company": {"former-conformed-name": "20/20 Global, Inc.", "date-changed": "20190102"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Myc
o
topia Therapies Inc.
(Exact name of registrant as specified in its charter)
Nevada
87-0645794
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
100 SE 2nd St
,
Suite 2000, Miami, FL
33131
(Address of Principal Executive Offices)
(Zip Code)
MYCOTOPIA THERAPIES INC. 2024 EQUITY INCENTIVE PLAN
(Full title of the plan)
InCorp Services Inc.
9107 West Russell Road Suite 100, Las Vegas, NV, 89148
(800) 246-2677
(Name and address of agent for service)
(Telephone number, including area code, of agent for service)
With copies to:
Jonathan D. Leinwand, P.A.
18305 Biscayne Blvd, Suite 200
Aventura, FL 33160
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
Accelerated filer
¨
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1. Plan Information.
The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants in the Mycotopia Therapies, Inc. 2024 Equity Incentive Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the "Securities Act"). Such documents are not being filed with the Securities and Exchange Commission (the "Commission") but constitute, along with the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Form S-8, a prospectus that meets the requirements of Section 10(a) of the Securities Act.
Item 2. Registrant Information and Employee Plan Annual Information.
Mycotopia Therapies, Inc. (the "Company") will furnish without charge to each person to whom the prospectus is delivered, upon the written or oral request of such person, a copy of any and all of the documents incorporated by reference in Item 3 of Part II of this Registration Statement, other than exhibits to such documents (unless such exhibits are specifically incorporated by reference to the information that is incorporated) and any other documents required to be delivered pursuant to Rule 428(b) under the Securities Act. Those documents are incorporated by reference in the Section 10(a) prospectus. Requests should be directed to the Secretary of the Company at the address and telephone number on the cover of this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Document by Reference.
The following documents have previously been filed by the Company with the Commission and are incorporated herein by reference:
a.
The Company's annual report on Form 10-K for the year ending December 31, 2023
b.
The Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024.
c.
The Company's Current Reports on Form 8-K filed with the Securities and Exchange Commission on March 28, 2024 and August 21, 2024.
d.
The description of the Company's securities as set forth in Item 11 of the Company's filing on Form 10, filed with the SEC on June 10, 2019, as amended, and any other amendment or report filed for the purpose of updating such description.
All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing such documents.
The Company will provide, without charge to each person, including any beneficial owner, to whom this document is delivered, upon written or oral request of such person, a copy of any or all of the documents incorporated herein by reference (other than exhibits, unless such exhibits specifically are incorporated by reference into such documents or this document). Requests for such documents should be submitted in writing, addressed to the office of the Secretary, Mycotopia Therapies Inc. 100 SE 2nd St, Suite 2000, Miami, FL 33131
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6.      Indemnification of Directors and Officers
Nevada law permits a Nevada corporation, such as the Company, to indemnify its directors and officers in certain circumstances. Specifically, Section 78.7502 of the Nevada Revised Statutes provides as follows:
(1)
A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company, against expenses, including attorneys' fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to Nevada Revised Statutes 78.138 or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was unlawful.
(2)
A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a manager of a limited-liability company, against expenses, including amounts paid in settlement and attorneys' fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification pursuant to this section may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of any appeals taken therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.
(3)
Any discretionary indemnification pursuant to this section, unless ordered by a court or advanced pursuant to subsection 2 of Nevada Revised Statutes 78.751, may be made by the corporation only as authorized in each specific case upon a determination that the indemnification of a director, officer, employee or agent of a corporation is proper under the circumstances. The determination must be made by: (a) the stockholders; (b) the board of directors, by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or (c) Independent legal counsel, in a written opinion, if: (1) A majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding so orders; or (2) A quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained."
The articles of incorporation of the Company provide that the Company shall indemnify, to the fullest extent legally permissible under the laws of the State of Nevada, each person who is or was a director or officer of the Company, or is or was serving as the request of the Company as a director or officer of another enterprise, and that the foregoing right of indemnification shall not exclude any other right to which a director or officer may be entitled under any bylaw, agreement, vote of stockholders, provision of law or otherwise. The Company's articles of incorporation also provide that no director or officer shall be personally liable to the corporation or its stockholders for damages for breach of fiduciary duty as a director or officer except for circumstances involving acts or omissions involving intentional misconduct, fraud or a knowing violation of law, or for unlawful distributions in violation of Section 78.300 of the Nevada Revised Statutes.
The bylaws of the Company provide that (i) the Company shall indemnify any person who is or was a director, officer (including the legal spouse of a director or officer), employee or agent of the Company; and (ii) the Company shall also indemnify any person who serves or served as a director, officer (including the legal spouse of such director or officer), employee or agent of any other enterprise at the request of the Company, if such person acted in good faith and in a manner reasonably believed to be in or not opposed to the best interest of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The indemnification of a legal spouse of a director or officer shall not extend to any claim for any actual or alleged wrongful act of the spouse but shall apply only to actual or alleged wrongful acts of a director or officer. The Company's bylaws also provide that expenses incurred in defending any civil or criminal action, suit or proceeding by any person who the Company is required to indemnify shall be paid as they are incurred upon receipt by the Company of an undertaking of such person to repay such expenses unless it should ultimately be determined that such person is entitled to be indemnified by the Company. The Company maintains director's and officers' liability insurance.
The foregoing is only a general summary of certain aspects of Nevada law, the Company's articles of incorporation and bylaws, and the insurance dealing with indemnification of directors and officers and does not purport to be complete. It is qualified in its entirety by reference to the detailed provisions of Nevada law, the Company's articles of incorporation and bylaws, and the insurance policies.
Item 8. Exhibits
Exhibit No.
Description
Location
4.1
Amended and Restated Articles of Incorporation of 20/20 Global, Inc.
Incorporated by reference from the registration statement on Form 10 filed April 15, 2019
4.2
Amendment to Articles of Incorporation
Incorporated by reference from the Quarterly Report on Form 10-Q
Filed on August 20, 2021
4.3
Bylaws of 20/20 Global, Inc.
Incorporated by reference from the registration statement on Form 10 filed April 15, 2019
4.4
Amendment to Bylaws
.
Incorporated by reference from the Quarterly Report on Form 10-Q filed May 20, 2021
4.5
Mycotopia Therapies Inc. 2024 Equity Incentive Plan
Filed Herewith
5.1
Opinion of Jonathan D. Leinwand, P.A.
Filed Herewith
23.1
Consent of
Jonathan D. Leinwand, P.A.
included in Exhibit 5.1
23.2
Consent of F
ruci
and Associates II LLP
Filed Herewith
23.3
Consent of Pinnacle Accountancy Group of Utah
Filed Herewith
107
Filing Fee Table
Filed Herewith
Item 9. Undertakings
(a)
The undersigned registrant hereby undertakes:
(1)    To file, during any period in which offers or sales are being made, a post-
effective amendment to this Registration Statement:
(i)    To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
(ii)    To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;
(iii)    To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.
(2)    That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3)    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b)    The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)    Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, on this 27th day of August, 2024.
MYCOTOPIA THERAPIES, INC.
By:
/s/ Benjamin Kaplan
Benjamin Kaplan,
Chief Executive Officer
(Principal Executive
Officer, Principal Financial Officer)
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Benjamin Kaplan
Chief Executive Officer and Director
September 13, 2024
Benjamin Kaplan
/s/ Mark Croskery
Director
September 13, 2024
Mark Croksery